Cargando…
Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET
BACKGROUND: The positron emission tomography (PET) radiotracer [(18)F]MK‐6240 exhibits high specificity for neurofibrillary tangles (NFTs) of tau protein in Alzheimer's disease (AD), high sensitivity to medial temporal and neocortical NFTs, and low within‐brain background. Objectives were to de...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983143/ https://www.ncbi.nlm.nih.gov/pubmed/36873926 http://dx.doi.org/10.1002/trc2.12372 |
_version_ | 1784900482950496256 |
---|---|
author | Shuping, Joanna L. Matthews, Dawn C. Adamczuk, Katarzyna Scott, David Rowe, Christopher C. Kreisl, William C. Johnson, Sterling C. Lukic, Ana S. Johnson, Keith A. Rosa‐Neto, Pedro Andrews, Randolph D. Van Laere, Koen Cordes, Lindsay Ward, Larry Wilde, Claire L. Barakos, Jerome Purcell, Derk D. Devanand, Davangere P. Stern, Yaakov Luchsinger, Jose A. Sur, Cyrille Price, Julie C. Brickman, Adam M. Klunk, William E. Boxer, Adam L. Mathotaarachchi, Sulantha S. Lao, Patrick J. Evelhoch, Jeffrey L. |
author_facet | Shuping, Joanna L. Matthews, Dawn C. Adamczuk, Katarzyna Scott, David Rowe, Christopher C. Kreisl, William C. Johnson, Sterling C. Lukic, Ana S. Johnson, Keith A. Rosa‐Neto, Pedro Andrews, Randolph D. Van Laere, Koen Cordes, Lindsay Ward, Larry Wilde, Claire L. Barakos, Jerome Purcell, Derk D. Devanand, Davangere P. Stern, Yaakov Luchsinger, Jose A. Sur, Cyrille Price, Julie C. Brickman, Adam M. Klunk, William E. Boxer, Adam L. Mathotaarachchi, Sulantha S. Lao, Patrick J. Evelhoch, Jeffrey L. |
author_sort | Shuping, Joanna L. |
collection | PubMed |
description | BACKGROUND: The positron emission tomography (PET) radiotracer [(18)F]MK‐6240 exhibits high specificity for neurofibrillary tangles (NFTs) of tau protein in Alzheimer's disease (AD), high sensitivity to medial temporal and neocortical NFTs, and low within‐brain background. Objectives were to develop and validate a reproducible, clinically relevant visual read method supporting [(18)F]MK‐6240 use to identify and stage AD subjects versus non‐AD and controls. METHODS: Five expert readers used their own methods to assess 30 scans of mixed diagnosis (47% cognitively normal, 23% mild cognitive impairment, 20% AD, 10% traumatic brain injury) and provided input regarding regional and global positivity, features influencing assessment, confidence, practicality, and clinical relevance. Inter‐reader agreement and concordance with quantitative values were evaluated to confirm that regions could be read reliably. Guided by input regarding clinical applicability and practicality, read classifications were defined. The readers read the scans using the new classifications, establishing by majority agreement a gold standard read for those scans. Two naïve readers were trained and read the 30‐scan set, providing initial validation. Inter‐rater agreement was further tested by two trained independent readers in 131 scans. One of these readers used the same method to read a full, diverse database of 1842 scans; relationships between read classification, clinical diagnosis, and amyloid status as available were assessed. RESULTS: Four visual read classifications were determined: no uptake, medial temporal lobe (MTL) only, MTL and neocortical uptake, and uptake outside MTL. Inter‐rater kappas were 1.0 for the naïve readers gold standard scans read and 0.98 for the independent readers 131‐scan read. All scans in the full database could be classified; classification frequencies were concordant with NFT histopathology literature. DISCUSSION: This four‐class [(18)F]MK‐6240 visual read method captures the presence of medial temporal signal, neocortical expansion associated with disease progression, and atypical distributions that may reflect different phenotypes. The method demonstrates excellent trainability, reproducibility, and clinical relevance supporting clinical use. HIGHLIGHTS: A visual read method has been developed for [(18)F]MK‐6240 tau positron emission tomography. The method is readily trainable and reproducible, with inter‐rater kappas of 0.98. The read method has been applied to a diverse set of 1842 [(18)F]MK‐6240 scans. All scans from a spectrum of disease states and acquisitions could be classified. Read classifications are consistent with histopathological neurofibrillary tangle staging literature. |
format | Online Article Text |
id | pubmed-9983143 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99831432023-03-04 Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET Shuping, Joanna L. Matthews, Dawn C. Adamczuk, Katarzyna Scott, David Rowe, Christopher C. Kreisl, William C. Johnson, Sterling C. Lukic, Ana S. Johnson, Keith A. Rosa‐Neto, Pedro Andrews, Randolph D. Van Laere, Koen Cordes, Lindsay Ward, Larry Wilde, Claire L. Barakos, Jerome Purcell, Derk D. Devanand, Davangere P. Stern, Yaakov Luchsinger, Jose A. Sur, Cyrille Price, Julie C. Brickman, Adam M. Klunk, William E. Boxer, Adam L. Mathotaarachchi, Sulantha S. Lao, Patrick J. Evelhoch, Jeffrey L. Alzheimers Dement (N Y) Research Articles BACKGROUND: The positron emission tomography (PET) radiotracer [(18)F]MK‐6240 exhibits high specificity for neurofibrillary tangles (NFTs) of tau protein in Alzheimer's disease (AD), high sensitivity to medial temporal and neocortical NFTs, and low within‐brain background. Objectives were to develop and validate a reproducible, clinically relevant visual read method supporting [(18)F]MK‐6240 use to identify and stage AD subjects versus non‐AD and controls. METHODS: Five expert readers used their own methods to assess 30 scans of mixed diagnosis (47% cognitively normal, 23% mild cognitive impairment, 20% AD, 10% traumatic brain injury) and provided input regarding regional and global positivity, features influencing assessment, confidence, practicality, and clinical relevance. Inter‐reader agreement and concordance with quantitative values were evaluated to confirm that regions could be read reliably. Guided by input regarding clinical applicability and practicality, read classifications were defined. The readers read the scans using the new classifications, establishing by majority agreement a gold standard read for those scans. Two naïve readers were trained and read the 30‐scan set, providing initial validation. Inter‐rater agreement was further tested by two trained independent readers in 131 scans. One of these readers used the same method to read a full, diverse database of 1842 scans; relationships between read classification, clinical diagnosis, and amyloid status as available were assessed. RESULTS: Four visual read classifications were determined: no uptake, medial temporal lobe (MTL) only, MTL and neocortical uptake, and uptake outside MTL. Inter‐rater kappas were 1.0 for the naïve readers gold standard scans read and 0.98 for the independent readers 131‐scan read. All scans in the full database could be classified; classification frequencies were concordant with NFT histopathology literature. DISCUSSION: This four‐class [(18)F]MK‐6240 visual read method captures the presence of medial temporal signal, neocortical expansion associated with disease progression, and atypical distributions that may reflect different phenotypes. The method demonstrates excellent trainability, reproducibility, and clinical relevance supporting clinical use. HIGHLIGHTS: A visual read method has been developed for [(18)F]MK‐6240 tau positron emission tomography. The method is readily trainable and reproducible, with inter‐rater kappas of 0.98. The read method has been applied to a diverse set of 1842 [(18)F]MK‐6240 scans. All scans from a spectrum of disease states and acquisitions could be classified. Read classifications are consistent with histopathological neurofibrillary tangle staging literature. John Wiley and Sons Inc. 2023-02-12 /pmc/articles/PMC9983143/ /pubmed/36873926 http://dx.doi.org/10.1002/trc2.12372 Text en © 2023 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals LLC on behalf of Alzheimer's Association. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made. |
spellingShingle | Research Articles Shuping, Joanna L. Matthews, Dawn C. Adamczuk, Katarzyna Scott, David Rowe, Christopher C. Kreisl, William C. Johnson, Sterling C. Lukic, Ana S. Johnson, Keith A. Rosa‐Neto, Pedro Andrews, Randolph D. Van Laere, Koen Cordes, Lindsay Ward, Larry Wilde, Claire L. Barakos, Jerome Purcell, Derk D. Devanand, Davangere P. Stern, Yaakov Luchsinger, Jose A. Sur, Cyrille Price, Julie C. Brickman, Adam M. Klunk, William E. Boxer, Adam L. Mathotaarachchi, Sulantha S. Lao, Patrick J. Evelhoch, Jeffrey L. Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET |
title | Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET |
title_full | Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET |
title_fullStr | Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET |
title_full_unstemmed | Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET |
title_short | Development, initial validation, and application of a visual read method for [(18)F]MK‐6240 tau PET |
title_sort | development, initial validation, and application of a visual read method for [(18)f]mk‐6240 tau pet |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9983143/ https://www.ncbi.nlm.nih.gov/pubmed/36873926 http://dx.doi.org/10.1002/trc2.12372 |
work_keys_str_mv | AT shupingjoannal developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT matthewsdawnc developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT adamczukkatarzyna developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT scottdavid developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT rowechristopherc developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT kreislwilliamc developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT johnsonsterlingc developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT lukicanas developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT johnsonkeitha developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT rosanetopedro developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT andrewsrandolphd developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT vanlaerekoen developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT cordeslindsay developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT wardlarry developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT wildeclairel developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT barakosjerome developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT purcellderkd developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT devananddavangerep developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT sternyaakov developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT luchsingerjosea developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT surcyrille developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT pricejuliec developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT brickmanadamm developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT klunkwilliame developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT boxeradaml developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT mathotaarachchisulanthas developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT laopatrickj developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet AT evelhochjeffreyl developmentinitialvalidationandapplicationofavisualreadmethodfor18fmk6240taupet |